TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MICROCYCLES

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MICROCYCLES

ST13

US500000079345480

Classe

1, 5, 42, 44

Pedido

79345480

Registro

7292296

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

21/05/2024

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 44

Data de depósito

25/02/2022

Data de registro

30/01/2024

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

30/01/2024

Última transação

30/01/2024

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

GB

Examinador

DIBLE, IAN

Unidade examinadora

M20

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Curve Therapeutics Limited

Representantes

Bruce S. Londa Norris McLaughlin, P.A.

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Chemicals for use in biotechnological product development; chemicals for use in biotechnological manufacturing processes; chemical preparations in the nature of biologically compatible chemical substances for scientific purposes other than for medical or veterinary use, namely, scientific, laboratory, clinical and medical research; biological tissue, namely, mammalian soft and hard tissues comprising or derived from stem cells or progenitor cells for scientific, laboratory, clinical and medical research; biological tissue, namely, biological tissue comprising or derived from stem cells or progenitor cells, and compositions thereof, for scientific, laboratory, clinical and medical research

Classe 5

Pharmaceutical preparations for cancer and neurological diseases for medical and veterinary use; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary use; dietary supplements for human beings and animals; dietary supplements; pharmaceutical preparations for use in oncology

Classe 42

Drug discovery and pharmaceutical drug development services; scientific services, namely, research in the field of pharmaceuticals, and new product development and design relating thereto; medical research; technological services, namely, research in the field of pharmaceuticals, and new product design relating thereto; new product design and development of medical technology; new product design and development of medical diagnostic apparatus; consultancy services relating to development of new technology for others in the field of pharmaceuticals and medical technology; industrial analysis, namely, consulting services in the field of industrial engineering; industrial research in the field of pharmaceuticals and medical technology; design and development of computer hardware and software; clinical research in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies, immuno-oncology, inflammation, haematology and infectious disease; scientific research in the nature of conducting clinical trials for others; scientific research in the nature of conducting clinical trials for pharmaceutical products; scientific screening and assaying in the nature of providing reagent sample testing and diagnostic services for others for scientific research purposes; chemical analysis; chemical research; biotechnology research; consultancy relating to biotechnology

Classe 44

Medical services; medical diagnostic testing services and prognostic medical services in the nature of medical consultations; veterinary services; medical analysis services relating to the treatment of persons; pharmaceutical advice; medical and health counseling services relating to antibodies, immuno-oncology, inflammation, haematology and infectious disease; medical screening and assaying in the nature of medical testing for diagnostic or treatment purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

21/05/2024

FICS

FINAL DISPOSITION NOTICE SENT TO IB

01/05/2024

FIMP

FINAL DISPOSITION PROCESSED

01/05/2024

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

30/04/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

30/01/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

30/01/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

13/01/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

27/12/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

27/12/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

14/11/2023

PUBO

PUBLISHED FOR OPPOSITION

14/11/2023

GPNX

NOTIFICATION PROCESSED BY IB

13/11/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

25/10/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

25/10/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/10/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/10/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/10/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/2023

ERFR

TEAS REQUEST FOR RECONSIDERATION RECEIVED

11/10/2023

GNFN

NOTIFICATION OF FINAL REFUSAL EMAILED

10/09/2023

GNFR

FINAL REFUSAL E-MAILED

10/09/2023

CNFR

FINAL REFUSAL WRITTEN

10/09/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/08/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/08/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/08/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

02/04/2023

RFNT

REFUSAL PROCESSED BY IB

06/03/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

14/02/2023

RFRR

REFUSAL PROCESSED BY MPU

14/02/2023

NREP

NEW REPRESENTATIVE AT IB RECEIVED

29/01/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

17/12/2022

CNRT

NON-FINAL ACTION WRITTEN

16/12/2022

DOCK

ASSIGNED TO EXAMINER

09/12/2022

MAFR

APPLICATION FILING RECEIPT MAILED

26/07/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

22/07/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

21/07/2022

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MICROCYCLES ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.